Lifecare

We are excited to introduce our new website - a refined digital representation of Lifecare. With user-friendly design and streamlined navigation, we have enhanced the experience for all stakeholders. We have also significantly improved our investor pages, ensuring they meet the need for accessible, transparent, and informative content. Our sincere thanks to our design agency Mission AS for their innovative design solution, navigation and layout. And to Kodex for expertly developing and structuring our publication platform. We invite you to explore our new site and hope you find it a valuable resource. Link in the comments 💬 #cgm #sensortechnology #medtech #diabetes #diabetestechnology Mission: Inki Annweiler Marius Holtmon Karl Martin Sætren 👏 Kodex: Marius Kaase Morten Virik 👏 Joacim Holter Renete Kaarvik Prof. Dr. Dr. med. Andreas Pfützner Jo Oeding Amundstad Asle Steiestøl Wingsternes Aslak Fisketjønn Julie Lundekvam Ahmad Fazli Barbora Tencer Jordan Gardiner Dr. Jeanette Hütges Dr. Preeti SHARMA Mandar Mehta Lenitha Schwartz Viktor Kolesnikov Vrushali Godse Torsten Ernst Lea Weingärtner Hendrick Jensch Morten Foros Krohnstad Trine Teigland Hans Hekland Tone Kvåle

Lifecare ASA listed on Euronext Oslo Børs Oslo Børs approved Lifecare’s transfer from Euronext Growth to Euronext Oslo Børs. Today, Lifecare’s management and board of directors rang the bell to mark the opening of the markets at Oslo Børs. - Taking the step to the regulated market Euronext Oslo Børs is an important milestone for Lifecare. On behalf of the entire organization, I am very proud that Oslo Børs has assessed and concluded that Lifecare meets the conditions for admission to the main list. We have proven the technology; we have focused on setting up production and we are now approaching our first product. Lifecare is ready for Euronext Oslo Børs, says CEO Joacim Holter. Lifecare has experienced a rapid development since we entered Euronext Growth six years ago. The organization has matured as we have prepared the company for Euronext Oslo Børs: 🚀 Over the past 3-4 years, the company has accelerated in technology, production preparations, organizational development and preparations for the commercialization phase. 🌍 developed from a listed start-up company to an international group with presence in Norway, Germany and England. 👥 increased the staff from 2 in 2020 to approximately 35 employees today. 👨💻 We have streamlined our administrative operations, balancing cutting-edge technological innovation with future commercialization efforts. - I am incredibly proud of the Lifecare team, who have worked tirelessly to bring us to this point. Looking forward, I am excited for the future as we aim to introduce the next generation of CGM-sensors to improve diabetes management for humans and pets, says Holter. - Diabetes is a pandemic of unprecedented magnitude spiralling out of control, affecting hundreds of millions of people worldwide. Our ambition is to make life easier, better, and more predictable for patients and pets with diabetes. Lifecare is dedicated to developing the next generation of miniaturized and implantable long-term Continuous Glucose Monitors to the market. Now, with the listing at Euronext Oslo Børs, we are making Lifecare more accessible to institutional and international investors, says Holter. #cgm #sensortechnology #medtech #diabetes #diabetestechnology Joacim Holter Renete Kaarvik Prof. Dr. Dr. med. Andreas Pfützner Jo Oeding Amundstad Asle Steiestøl Wingsternes Aslak Fisketjønn Julie Lundekvam Ahmad Fazli Barbora Tencer Jordan Gardiner Dr. Jeanette Hütges Dr. Preeti SHARMA Mandar Mehta Lenitha Schwartz Vrushali Godse Torsten Ernst Hendrick Jensch Morten Foros Krohnstad Trine Teigland Hans Hekland Tone Kvåle 📸 Thomas Brun / NTB: Lifecare’s management and board of directors rang the bell to mark the opening of the markets at Oslo Børs.

This week, Lifecare presented an update on our data from human studies and the ongoing longevity study in dogs at the #DiabetesTechnologyMeeting2024 in #Burlingame #California. The #DTM is hosted by the #DiabetesTechnologySociety founded by David Klonoff, the chairman of Lifecare Scientific Advisory Board. The DTM was finally back to in-person meeting and it was fantastic to be back at this very important and very well organized conference! Among loads of high end scientific talks at this years DTM, Guido Freckmann from the “Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm” made a sidenote in his talk that his group have tested non-invasive glucose sensors in smartwatches bought online. The first measurements was done on humans, with an approved CGM as reference. The smartwatches did not perform well! But most interesting was that the experiment also included to mount the smartwatches on a banana, and it turned out that the measurements and the data profile from the banana was the identical with the results from the test person. A funny story, with the serious indication that glucose must be measured inside the body! Lutz, Prof. Dr. Heinemann Niels Ejskjaer David Kerr MD Prof. Dr. Dr. med. Andreas Pfützner Chris Dawson James Gooch Morten Foros Krohnstad Trine Teigland Hans Hekland Tone Kvåle Renete Kaarvik Barbora Tencer Ahmad Fazli Jo Oeding Amundstad Aslak Fisketjønn Asle Steiestøl Wingsternes Julie Lundekvam

Starting an exciting week with the staff in Bergen - we are in the final phase prior to our entry into Euronext Oslo Børs on Tuesday next week and also have a technology presentation given by Joacim Holter at the Annual Conference of Diabetes Technology Society (DTS) in San Francisco on Thursday organized and chaired by the head of our scientific advisory board David Klonoff It is fun to be part of such a motivated and passionate team here at Lifecare Julie Lundekvam Lenitha Schwartz Ahmad Fazli Asle Steiestøl Wingsternes Jo Oeding Amundstad Viktor Kolesnikov

Watch Lifecare's company presentation at the LSX Nordic Congress 2024 in Copenhagen this week. The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region. The congress connects life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic & Baltic life science and healthcare innovation. You will find the link to the presentation in the comments below 👇 #cgm #sensortechnology #medtech #diabetes #diabetestechnology Joacim Holter Renete Kaarvik Prof. Dr. Dr. med. Andreas Pfützner Jo Oeding Amundstad Asle Steiestøl Wingsternes Aslak Fisketjønn Julie Lundekvam Ahmad Fazli Barbora Tencer Jordan Gardiner Dr. Jeanette Hütges Dr. Preeti SHARMA Mandar Mehta Lenitha Schwartz Vrushali Godse Torsten Ernst Hendrick Jensch Morten Foros Krohnstad Trine Teigland Hans Hekland Tone Kvåle

Carnegie Investment Bank initiated a commissioned research coverage of Lifecare last week, and analyst Ludvig Svensson appeared in the latest episode of #Penserpodden presenting a quick introduction of the research report. The podcast is in Swedish and the section starts 20 minutes into the episode. Enjoy! https://lnkd.in/dxZsjfmX

Onsite bellacenter in Copenhagen with Renete Kaarvik and ready for the first day of the conference LSX - partnering for Life Science eXecutives Nordic Congres 2024. Look forward to meet potential investors and to present Lifecare at 11:30 today.

Publication of approved prospectus Reference is made to the stock exchange announcement made by Lifecare ASA on 2 October 2024. Then we announced the key terms of the retail offering of up to 1,000,000 new shares to the public in Norway, Sweden and Denmark, on the terms and conditions in the prospectus published by the Company in connection with the Offering and the listing of the Company’s shares on Oslo Børs, alternatively Euronext Expand. The Prospectus was approved by the Norwegian Financial Supervisory Authority on 3 October 2024. The Prospectus is published today, 4 October 2024, and is available in the link in the comments below. Carnegie Investment Bank is acting as manager in connection with the Offering and Listing. Nordnet Bank AB is acting as placing agent in the Offering. Schjødt AS is acting as Norwegian legal counsel to the Company #cgm #sensortechnology #medtech #diabetes #diabetestechnology Joacim Holter Renete Kaarvik Prof. Dr. Dr. med. Andreas Pfützner Jo Oeding Amundstad Asle Steiestøl Wingsternes Aslak Fisketjønn Julie Lundekvam Ahmad Fazli Barbora Tencer Jordan Gardiner Dr. Jeanette Hütges Dr. Preeti SHARMA Mandar Mehta Lenitha Schwartz Vrushali Godse Torsten Ernst Hendrick Jensch Morten Foros Krohnstad Trine Teigland Hans Hekland Tone Kvåle

First successful production based on automatization of critical processes. Lifecare’ manufacturing department has successfully executed production of Sencell sensors at our laboratory in Reutlingen, based on automated processes. 🪜 We have now automated the most critical steps in the production process, transitioning from partially hand-made sensors towards automated production. The achievement demonstrates our ability to conduct automated production of glucose monitoring sensors for both humans and pets. 🧩  We are very pleased that our innovative glucose sensor, which has a complex structure, can also be produced based on the automatically processes with the equipment that we have invested in and spent time adapting to our production purpose. 🚀 While the current automated production is not at a volume scale, it significantly enhances the efficiency of the process and increases sensor output. 🔁 We will now repeat the production based on automated processes at our pilot manufacturing unit in Mainz and continue the process improvements towards scalable production, says Holter. The sensors that have been produced are now subject to internal in vitro sensor quality control and bacteriological testing. Subject to quality approval, the newly manufactured sensors will be used in the second phase of the longevity study organized by Lifecare Veterinary, starting in the next few weeks. #cgm #sensortechnology #medtech #diabetes #diabetestechnology Joacim Holter Renete Kaarvik Prof. Dr. Dr. med. Andreas Pfützner Jo Oeding Amundstad Asle Steiestøl Wingsternes Aslak Fisketjønn Julie Lundekvam Ahmad Fazli Barbora Tencer Jordan Gardiner Dr. Jeanette Hütges Dr. Preeti SHARMA Mandar Mehta Lenitha Schwartz Vrushali Godse Torsten Ernst Hendrick Jensch Morten Foros Krohnstad Trine Teigland Hans Hekland Tone Kvåle

The consolidation (reverse split) of shares has been completed and change of par value is set. The reverse split was carried out in the ratio of 13:1. The share consolidation has now been registered with the Norwegian Register of Business Enterprises, and the Company’s share capital is NOK 78,112,907.60 (unchanged) divided on 15,021,713 shares, each with a nominal value of NOK 5.20. This consolidation is as of today reflected in the share traded at Euronext Growth. Morten Foros Krohnstad Trine Teigland Hans Hekland Tone Kvåle Joacim Holter Renete Kaarvik Prof. Dr. Dr. med. Andreas Pfützner Jo Oeding Amundstad Asle Steiestøl Wingsternes Aslak Fisketjønn Julie Lundekvam Ahmad Fazli Barbora Tencer Jordan Gardiner Dr. Jeanette Hütges Dr. Preeti SHARMA Mandar Mehta Lenitha Schwartz 📸 Euronext Oslo Børs